School of Medicine
Showing 1,301-1,350 of 2,425 Results
-
Anurag Mairal
Adjunct Professor, Medicine - Cardiovascular Medicine
Adjunct Professor, Medicine - Cardiovascular MedicineBioDr. Anurag Mairal is an Adjunct Professor of Medicine and the Director, Global Outreach Programs at Stanford Mussallem Center for Biodesign, Stanford University. He is also a Faculty Fellow and Lead for Technology Innovation and Impact at Center for Innovation in Global Health. In these roles, he leads initiatives focused on applying the biodesign process to resource-constrained settings globally. Further, he facilitates opportunities for students, faculty and fellows at Stanford to work on global healthcare needs. He is founding co-Director for MED 232, Global Health: Scaling Health Technology Innovations in Low Resource Settings, and was part of the founding faculty team for BIOE 371, Global Biodesign: Medical Technology in an International Context, graduate-level courses offered to engineering, business, and medical students at Stanford University. Earlier, he served as Associate Director for the Stanford-India Biodesign and Singapore-Stanford Biodesign programs. He serves as the Founding Chair of BME IDEA APAC, a community of medtech innovation programs in Asia Pacific, partnering closely with the industry and academia in the region. He is also an Honorary Professor at University of Cape Town, South Africa. Concurrently, he is a co-founder and Executive Vice President of Orbees Medical, a SF Bay Area-based strategy consulting firm serving global healthcare industry, with a focus on medtech, pharmaceutical, and digital health industry.
Dr. Mairal has an extensive background in medical technology development and commercialization, collaborating with partners in the U.S., India, China, and other emerging markets to advance product development, manufacturing, and distribution. Recently, he took a sabbatical for two years to take a senior leadership role at PATH, a major global health nonprofit based in Seattle. In this role, he oversaw research and development, commercialization, and implementation of technologies in PATH’s medical devices, diagnostics, and digital health divisions. Previously, he held several positions at Johnson & Johnson, including Business Development Director and Product Director for structural heart, cardiology, and peripheral vascular products at Cordis. Before joining J&J, he was a Group Leader and a Process Development Manager at Membrane Technology and Research (MTR). At MTR, he was responsible for business development, strategic alliances, and product development in the bioseparations area. An active mentor to entrepreneurs and industry professionals, he serves as the chair of PATH’s Bay Area Leadership Council; co-chair of the global advisory board at EPPIC Global Network; chair of Faculty Alumni Network and member of the Board Executive Committee at IIT Bombay Heritage Foundation; and President of Sewa International - Bay Area.
Dr. Mairal earned a PhD in chemical engineering from the University of Colorado at Boulder and an MBA from the Haas School of Business at the University of California at Berkeley. He also holds an MS in chemical engineering from the Indian Institution of Technology in Mumbai and a BS in chemical engineering from National Institute of Technology, Raipur. Dr. Mairal was a post-doctoral fellow at the University of Twente, Netherlands and at University of Michigan, Ann Arbor. At BerkeleyHaas, he was a founding co-Chairman of the South Asia Business Conference and Chair of the Biotech Panel for the Asia Business Conference. His work has been published in more than 30 publications, and he has seven issued patents. -
Amrapali Maitra
Clinical Assistant Professor, Medicine
BioAmrapali Maitra is a clinician, educator, and scholar with training from Harvard and Stanford as well as a Paul and Daisy Soros Fellow for New Americans (2013). Her clinical practice emphasizes humanism and attention to health equity through structural competency. As an educator, she is committed to diversity and inclusion in the learning environment for pre-medical, medical, and graduate medical trainees, as well as centering patients as teachers. Her scholarship focuses on intimate partner violence, trauma-informed care, medical education, and the humanities.
-
Ravi Majeti MD, PhD
Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Virginia and D. K. Ludwig Professor and Professor of Medicine (Hematology/Stem Cell Institute)
Current Research and Scholarly InterestsThe Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.
-
Joshua Makower
Yock Family Professor and Professor of Bioengineering
Current Research and Scholarly InterestsDr. Josh Makower is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering and the Director of the Stanford Byers Center for Biodesign, the program he co-founded with Dr. Paul Yock twenty years ago. Josh helped create the fundamental structure of the Center’s core curriculum and is the chief architect of what is now called “The Biodesign Process.” Over the past 20 years since Josh and Paul founded Biodesign, this curriculum and the associated textbook has been used at Stanford and across the world to train hundreds of thousands of students, faculty and industry leaders on the Biodesign process towards the advancement of medical innovation for the improvement of patient care. Josh has practiced these same techniques directly as the Founder & Executive Chairman of ExploraMed, a medical device incubator, creating 9 companies since 1995. Transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex, Acclarent, acquired by J&J, EndoMatrix, acquired by C.R. Bard & TransVascular, acquired by Medtronic. Other ExploraMed/NEA ventures include Moximed, NC8 and Willow. Josh is also a Special Partner at NEA where he supports the healthcare team and medtech/healthtech investing practice. Josh serves on the boards of Allay Therapeutics, Revelle Aesthetics, Setpoint Medical, DOTS Technologies, Eargo, ExploraMed, Intrinsic Therapeutics, Moximed, Willow and Coravin. Josh holds over 300 patents and patent applications. He received an MBA from Columbia University, an MD from the NYU School of Medicine, a bachelor’s degree in Mechanical Engineering from MIT. Josh is a Member of the National Academy of Engineering and the College of Fellows of The American Institute for Medical and Biological Engineering and was awarded the Coulter Award for Healthcare Innovation by the Biomedical Engineering Society in 2018.
-
Jose R. Maldonado, MD, FACLP, FACFE
John and Terry Levin Family Professor of Medicine and Professor, by courtesy, of Emergency Medicine and of Medicine
Current Research and Scholarly InterestsPathophysiology and Management of Delirium, Acute Brain Failure and Cognitive Impairment, Neuropsychiatric Sequelae of Traumatic Brain Injury, Factitious Disorder & Munchausen's Syndrome, Cultural Diversity in Medical Care, Psychiatric Complications of Bone Marrow Transplantation, Conversion Disorder, Depression in the Medically Ill, Neuropsychiatric Sequelae of Chronic Fatigue Syndrome.
-
Kristine Isabel M. Mallari
Research Nurse, Medicine - Primary Care and Population Health
BioKristine is a dedicated Registered Nurse with a Bachelor's Degree in Nursing and nearly a decade of diverse experience in the healthcare field. Throughout her career, she has provided compassionate care to patients across various settings, including inpatient and outpatient environments, as well as specialty areas such as Nephrology Nursing. Her journey has led her to her current role as a Clinical Research Nurse within the Geriatric Research department at Stanford University in the last three years.
-
Galina Malukhina
Director of Finance, Medicine
Current Role at StanfordI joined Stanford University in 2004 and have held various roles on campus in the School of Humanities & Sciences and the School of Medicine. My background is in financial management, infrastructure, faculty compensation, and process improvement, with a keen focus on client service. I tremendously value and support partnerships and continuously explore ways of enhancing collaboration and transparency. I also have a deep appreciation for healthcare, research, and teaching, and I enjoy working alongside faculty and staff in an academic environment.
-
Gabriel Mannis
Associate Professor of Medicine (Hematology)
Current Research and Scholarly InterestsMy research focuses on the development of more effective, less toxic therapies for patients with AML and other high-risk hematologic malignancies. We study biologic correlates that predict response to therapy as well as factors/interventions that improve quality-of-life for patients struggling with blood-borne cancers.
-
Neha Maheshwari Mantri
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Neha Mantri serves as the Director of the Structural Imaging Program and Director of the Women’s Cardiology Clinic at Palo Alto VA Health Care System (PAVA HCS). Given her expertise in advanced imaging, she serves as a reader in the Echocardiography Lab at Stanford Hospital. She also leads several echocardiography quality improvement projects, weekly multi-modality imaging educational seminars, and fellow workshops across the PAVA HCS and Stanford echo labs.
-
Arek Melkon Manugian, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Manugian is a board-certified internal medicine doctor at Stanford Primary Care in Portola Valley. He is also a clinical assistant professor in the Division of Primary Care and Population Health in the Department of Medicine at Stanford University School of Medicine.
He has experience diagnosing, managing, and treating a wide range of conditions. These include gastrointestinal disorders, hypertension (high blood pressure), and obesity. Dr. Manugian develops an individualized care plan for each one of his patients.
Dr. Manugian’s research interests include blood pressure medication, gastric bypass surgery, and restless legs syndrome. He received a student research grant to study how the body processes glucagon (a hormone that regulates blood sugar) following gastric bypass surgery. Dr. Manugian has also studied muscle inflammation as a rare side effect of statins (drugs that lower cholesterol). He monitored a clinical trial evaluating the prescribing of drugs to lower high blood pressure. As a clinical research associate at the Stanford University Center for Sleep Sciences and Medicine, Dr. Manugian studied medications to treat restless legs syndrome.
Dr. Manugian presented research to his peers during his residency at the University of Cincinnati Medical Center. He has taught medical students, residents, and physicians about a variety of topics, including alcohol abuse, tick-born illnesses, and managing indigestion.
Dr. Manugian is a member of the American College of Physicians. -
Jill Marcus
Senior Manager, CEC & Clinical Research, Med/Stanford Center for Clinical Research
Current Role at StanfordSenior Manager, CEC and Clinical Research
-
Robert Marcus
Professor (Clinical) of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly InterestsI have been retired since 2008 and no longer conduct research
-
Jessie Markovits, MD
Clinical Associate Professor, Medicine
Clinical Associate Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsHypnosis for perioperative symptom management in elective orthopedic surgery.
-
Meghan Marmor
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Marmor is board certified in pulmonary and critical care medicine. She specializes in the treatment of individuals with chronic airway diseases, bronchiectasis, and chronic lung infections.
-
David J. Maron
C. F. Rehnborg Professor and Professor of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsDr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.
-
Ashley Martinez, MD, MAS
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Ashley Martinez is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
Dr. Martinez specializes in caring for kidney transplant recipients. She has expertise in pre-transplant evaluation and readiness, immunosuppression, kidney allograft survival, and the prevention and treatment of post-transplant complications. She prioritizes clear, personalized communication at every point to improve care.
Dr. Martinez earned her medical degree from Harvard Medical School and completed her residency in internal medicine at Massachusetts General Hospital. She completed clinical and research fellowships in nephrology at the University of California, San Francisco (UCSF), where she also earned a master’s degree in clinical research. She completed her transplant nephrology fellowship at Stanford University School of Medicine.
Dr. Martinez’s research interests focus on addressing the needs of patients impacted by language barriers. Her work has emphasized the need to improve provider-patient communication, patient education, and evaluation tools for patients with limited English proficiency. She aims to increase awareness of communication gaps and increase patient-centered communication throughout the course of kidney care.
Dr. Martinez has published her findings in peer-reviewed journals including JAMA Network Open and Kidney360. She has also presented at the National Kidney Foundation Spring Clinical Meetings.
Dr. Martinez is a member of the American Society of Nephrology, the American Society of Transplantation, and the National Kidney Foundation.
